Study of the activity of antithrombin-III in latent cholestasis. (A clinico-pharmacological study of the relationship between antithrombin-III activity and steroid cholestasis).
The relationship between steroid cholestasis and antithrombin-III activity were examined in users of oral contraceptives (Infecundin or Bisecurin) and in patients receiving anabolic hormone therapy (Nerobol). The control group for the oral contraceptive users consisted of patients with spontaneous anovulation. The untreated control group consisted of healthy women in the reproductive age. The increase in antithrombin-III activity was found to be directly related to the decline of anion excretion. Latent cholestasis in itself is not associated with an increased antithrombin-III activity, nor is the activity of antithrombin-III affected by long-continued use of those anabolic steroids which produce no decrease in anion excretion.
D000328:Adult; D000858:Anovulation / Q000097:blood; D000990:Antithrombin III / Q000032:analysis*; D002779:Cholestasis / Q000097:blood* / Q000139:chemically induced / Q000175:diagnosis; D003276:Contraceptives, Oral / Q000009:adverse effects*; D003277:Contraceptives, Oral, Combined / Q000009:adverse effects*; D005260:Female; D006493:Heparin / Q000494:pharmacology; D006801:Humans; D008111:Liver Function Tests; D008696:Methandrostenolone / Q000009:adverse effects*
D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D000990:Antithrombin III; D006493:Heparin; D008696:Methandrostenolone